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INTRODUCTION 
The incidence of post-traumatic epilepsy (PTE), 
that is, persistent seizure activity following 
significant head trauma, varies with the type and 
severity of the head injury, i.e. depressed skull 
fractures, haematomas, and penetrating head 
injuries. Many other factors also appear to 
determine the risks for developing PTE, such as 
the length of time for which a person is 
unconscious following the injury, the develop- 
ment of intracranial pressure or haemorrhage, 
focal neurological signs, location of the injury, 
and age 1. 
A common preventative treatment for the 
recurrence of PTE is the administration of 
anticonvulsant drugs. The idea of pharmacologi- 
cal prophylaxis of PTE is based on the clinical 
observation that there is a delay, described by 
Glotzner 2 as an 'incubation period', between 
brain injury and the first seizure. 
Animal studies have been conducted to ex- 
amine the effects of anticonvulsant drugs on 
behavioural recovery from brain damage. Ani- 
mals, including humans, show a remarkable 
capacity for recovery after brain injury. It is clear 
that many of the drugs administered to patients 
after head injury have pronounced effects on 
neuronal function and could influence the rate or 
extent of recovery. 
Although anticonvulsant drugs are commonly 
given prophylactically to humans following brain 
injury, there is very little information about their 
effects upon subsequent behavioural recovery. It 
has, however been argued by Pellock 3 that 
overall, there is only an approximate 5% risk, 
post brain injury, of developing PTE which 
suggests that the remaining 95% may receive 
anticonvulsants needlessly. This review will ex- 
amine what is known about the effects of PTE 
and anticonvulsant drugs on recovery of function 
from experimental brain damage, on the basis of 
several experimental nimal studies which have 
attempted to address this issue over the past 10 
years. The review will look first at two animal 
models: amygdala kindling, which is used as a 
model for human epilepsy; and a model of 
neurological effects of brain damage. PTE, 
anticonvulsants and recovery of function follow- 
ing experimental brain damage will then be 
discussed. 
ANIMAL MODELS 
Amygdala kindling 
The kindling model of epilepsy which was first 
described by Goddard et al 4 has been proposed as 
a suitable animal model for studying anticonvul- 
sant tolerance in complex partial epilepsy 5.
Kindling refers to a phenomenon in which 
repeated, brief, subthreshold electrical stimula- 
tion of discrete brain regions produces a progres- 
sive increase in behavioural and electroen- 
cephalographic (EEG) response, resulting ultim- 
ately in a fully generalized EEG seizure and 
motor convulsion 6. This response is permanent 
and develops without production of tissue 
damage 43. Racine 8 defined a grading system, 
according to the level of behavioural response 
elicited. Behavioural seizures generally evolve 
through five stages: 0, no response; 1, facial 
movements; 2, facial movements with head- 
nodding; 3, forelimb clonus; 4, rearing onto hind 
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limbs with forelimb clonus; 5, rearing onto hind 
limbs and falling 8. According to Loscher et al 5, 
behaviour observed in stages 1 and 2 mimics 
human complex partial seizures, stage 3 mimics 
focal seizure activity, and fully kindled rats 
'exhibit a behaviour consistent with complex 
partial seizures evolving to generalised motor 
seizure.' Thus the study of kindling has been 
utilized extensively in animal experimentation in 
the hope that it will provide insight into the 
mechanisms of neuronal plasticity and human 
epilepsy 7.
Drug-induced seizures 
A chemoconvulsant, pentylenetetrazol (PTZ), 
has also been widely used in the assessment of the 
efficacy of anticonvulsant drugs in animal models 
of epilepsy because chronic, low dose, ad- 
ministration of PTZ yields mild siezures. It has 
been hypothesized that this occurs due to the 
blocking of GABA-induced inhibition via the 
picrotoxin recognition site in certain brain 
regions 9.Assessment of convulsive behaviour in 
animals post-injection is usually performed ac- 
cording to the scale of Ito et al in which, 0 = no 
convulsions; 1 = head or body twitching; 2 = 
clonic forelimb convulsions; 3=rearing; and 
4 = falling back 9. These behaviour responses have 
been observed to occur within the first 20- 
30 minutes post-injection. 
A model of the neurological effects of brain 
injury 
Unilateral damage to the anterior medial cortex 
(AMC) or sensorimotor cortex (SMC) of the rat 
brain has been shown to cause a distinct 
somatosensory asymmetry, that is, a quantifiable 
(see below), one sided deficit in the rat's limb 
functioning. Rats have been shown to respond 
consistently to stimuli ipsilateral to the lesion 
over the contralateral stimulus. A lesion which is 
electrolytically induced is known to expand 
rapidly during the immediate post-operative 
period, being maximal by about 8-10hours 
post-surgery 1°.This suggests that with stabiliza- 
tion at this point, any administration of a drug 
after this period would be unlikely to affect the 
size of the lesion ~°. 
Used singly or in combination these models 
have allowed for the study of PTE and its effects 
on recovery of function following experimental 
brain damage. They have also helped to elucidate 
the effects of anticonvulsants given prophylacti- 
cally on recovery of function following ex- 
perimental brain damage and the effectiveness of 
anticonvulsants in preventing PTE. This review 
will concentrate solely on work done in the first of 
these areas. 
BEHAVlOURAL TESTING 
Somatosensory asymmetry 
Assessment of somatosensory asymmetry is per- 
formed in all rats pre- and post-operatively. 
Initially, small pieces of adhesive-backed paper 
(113.1mm2) are placed on the wrist of each 
forelimb in the distal-radial region; these are 
used as bilateral tactile stimuli. Animals are 
removed from their cages briefly, the stimuli are 
applied and then the animals are returned to their 
cage. Rats will quickly and reliably remove and 
discard these stimuli with their teethlL The time 
taken for the rat to contact each stimulus and the 
subsequent time taken to remove each stimulus 
are recorded across a number of trials. The order 
of the stimulus removal reveals any somatosen- 
sory asymmetries in the animals, that is, animals 
contacting the forelimb ipsilateral to the lesion 
consistently, whilst constantly ignoring the con- 
tralateral stimulus,, are defined as demonstrating 
somatosensory asymmetry. If an animal displays 
any asymmetry before surgery then the lesion is 
placed on the opposite side of the bias in order to 
control for endogeneous asymmetry. Thus, any 
post-operative bias would be due to the lesion. 
This test is unaffected by practice 1°. 
A second somatosensory test is carried out 
post-operatively to assess the magnitude of 
asymmetry in rats that show a somatosensory bias 
ipsilateral to the lesion. In this test the size of the 
contralateral stimulus is systematically increased, 
while the size of the ipsilateral stimulus is 
simultaneously decreased by equal amounts, that 
is, the ipsilateral stimulus is decreased by 
14.1mm 2 whilst the contralateral stimulus is 
systematically increased by 14.1mm 2. With 
sufficient increase in the contralateral/ipsilateral 
ratio, the bias is neutralized. With further 
increases in the contralateral/ipsilateral ratio, the 
bias can be reversed and the rat will begin to 
respond to the contralateral stimulus first. It has 
been shown that the contralateral/ipsilateral ratio 
necessary to balance or reverse an ipsilateral bias 
is proportional to the degree of brain damage and 
that during recovery this ratio progressively 
decreases. Thus, changes in the magnitude of 
asymmetry can be quantified over time, and 
reflect recovery of somatosensory function 1°. 
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Motor coordination test 
This test assesses limb use and placement. Rats 
are placed on an elevated grid for two minutes. 
They usually use the wire frame as foot-holds but 
occasionally a limb will fall through a grid 
opening (3 cm × 3 cm) and these are classed as 
'foot-faults'. Rats are tested on the grid pre- and 
post-operatively and hindlimb/forelimb, left and 
right foot faults are recorded. Preoperatively the 
foot-faults are usually symmetrical. 
recovered induces a transient (2-3 day) somato- 
sensory asymmetry. They went on to attempt o 
determine a period of time, post AMC lesion, 
during which recovery processes are vulnerable to 
drug manipulations. They did this by administer- 
ing initial injections of diazepam at 12, 42, 84, or 
168 hours post-lesion and found a sensitivity to 
diazepam within a period of 12-96 hours. How- 
ever, this was subject o individual differences; in 
general, diazepam did not prevent recovery if a 
measurable recovery was observed prior to the 
initial injection ~5. 
POST-INJURY NEURONAL DEPRESSION 
(DIASCHISIS) 
Van Monakow ~2 referred to the condition of 
post-injury neuronal depression as diaschisis, that 
is, a temporary disruption of neuronal activity in 
undamaged areas functionally related to injured 
areas. Post-traumatic neuronal depression may 
contribute to the severity of sensorimotor deficits 
observed following brain damage. 
As long ago as 1945, the effects of anticonvul- 
sant drugs on recovery of function were first 
examined: Watson and Kennard showed how, 
following cerebral cortical lesions in monkeys, 
administration of phenobarbital s owed recovery 
from experimental hemiplegia nd they hypothe- 
sized that convulsant drugs might facilitate 
recovery ~3. More recently, it has been demonstr- 
ated that amphetamine administration acceler- 
ates the recovery of beam-walking ability in rats 
following a cortical lesion ~4, whilst diazepam, 
which is an effective anticonvulsant, prevents 
recovery from induced somatosensory asymmetry 
in rats ~°. Shallert et al ~° found that, following 
damage to the AMC in rats, diazepam interfered 
with recovery from somatosensory asymmetry. 
Following a chronic regime of diazepam post- 
operatively, recovery of somatosensory asym- 
metry in AMC lesioned rats was prevented after 
22 days post-operative whilst undrugged rats had 
recovered fully in 7-10 days. This, Shallert et al 
suggest, supports the hypothesis that GABAergic 
activity (which is inhibitory), when enhanced may 
prevent recovery of normal function in the AMC 
and connecting structures which 'may have 
become deactivated due to denervation.' 
In a series of experiments Schallert et aP ° 
demonstrated not only how a chronic regime of 
diazepam prevents recovery from somatosensory 
asymmetry post-lesion, but also that administra- 
tion of diazepam after rats have completely 
Effects of GABA 
Brailowsky et a116 reported that hemiplegia in 
rats, induced by motor cortex lesions, was 
enhanced by intracortical infusions of GABA.  
This, it was believed, was due to the enhancement 
of depression in brain areas related to, but 
undamaged by, the lesion. Hernandez and 
Schallert 9 hypothesized that, if this was the case, 
then reduction of GABAergic activity might have 
the opposite effect, i.e. the facilitation of re- 
covery. They tested this by examining the effects 
of mild infrequent seizures on recovery from 
experimental brain damage 9. Hernandez and 
Shallert 9 assessed 16 rats preoperatively on 
somatosensory asymmetry tests and motor coor- 
dination tests and then all rats sustained SMC 
lesions. At 16-18 hours post-operative, one half 
of the rats commenced a chronic regime of PTZ 
while the other half (control) received a chronic 
regime of saline. These were administered three 
times a day for the first three days and twice a day 
for the following 19 days. PTZ doses were initially 
45 mg/kg followed by two doses of 30 mg/kg and 
thereafter of 15 mg/kg. Subsequent somatosen- 
sory and motor coordination tests were per- 
formed on selective days (2, 6, 16, 22, 45, 60) 
post-operatively. It was found that recovery was 
significantly faster in rats receiving PTZ than in 
those receiving saline, the former recovering 
within three weeks and the latter two months 
post-surgery. Although PTZ was beneficial to 
recovery from somatosensory asymmetry, it had 
no effect on motor coordination deficits. Other 
studies have supported these findings and have 
shown that mild, infrequent seizures can facilitate 
behavioural recovery 9'x4'17. From these findings, 
Hernandez and Schallert 9 concluded that if 
post-traumatic seizures can weaken neuronal 
depression, then behavioural recovery might be 
enhanced if a partial prevention of seizures is 
allowed rather than complete prevention. 
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Benzodiazepines and barbiturates 
Diazepam has been found to delay recovery from 
somatosensory asymmetry post unilateral AMC 
lesion and is believed to do so by enhancing 
inhibitory neurotransmission at the GABA/ 
benzodiazepine r ceptor complex ~8-2°. Diazepam 
not only enhances GABAergic activity but it also 
reduces cerebral glucose utilization 21"22 and, in 
certain doses, causes sedation and reduced 
locomotion activity 23. 
This was investigated by Hernandez et a125, 
who used a benzodiazepine (BZ) antagonist RO 
15-1788 (RO) to prevent diazepam-induced re- 
tardation of recovery of function. They adminis- 
tered a seven-day regime of RO 15-1788 and 
diazepam (RO + DZ); RO 15-1788 alone (RO); 
diazepam alone (DZ); and vehicle (VEH) injec- 
tions to four separate groups of AMC lesioned 
rats, respectivoly, and found that the RO and DZ 
group of rats recovered from somatosensory 
asymmetry as quickly as vehicle treated rats. The 
antagonist RO when given alone or in combina- 
tion with DZ had no effect on recovery from 
somatosensory asymmetry. However, DZ-treated 
rats had still not recovered from somatosensory 
asymmetry 28 days post-lesion. From this the 
investigators presumed that the antagonist RO 
15-1788 prevented iazepam from acting at the 
BZ recognition site. 
DISCUSSION 
The effects of PTE appear to be bimoda124. The 
research outlined above shows that mild, infre- 
quent seizures might favourably effect behaviour 
recovery in certain cases, post brain injury; other 
work however, has found that severe or frequent 
seizures may cause further brain damage or 
intractable epilepsy '7. Uncontrolled seizures 
(stage 5), may be the major factor causing death 
after mild injury 26. Seizures of such severity can 
lead to neuronal degeneration, deprive the 
neurones of energy, and also cause an increased 
influx of calcium and efflux of potassium. Choi 27 
has shown that such an effect induces cell death 
after just 5 minutes. Status epilepticus (repeated, 
uncontrolled, generalized motor seizures), would 
be equivalent o sustained (5 minutes) transient 
exposure. Brain injury leads to a disruption of 
normal brain function which, as Naritoka and 
Hernandez 24point out, 'could result in a state that 
both primes the brain for acute seizures and 
provides the foundation for long-term changes 
that render the brain chronically epileptic.' 
PTE presents significant problems for re- 
habilitation with the impact of uncontrolled 
epilepsy being greatest. Walker 28 found that 
World War II veterans who developed PTE post 
brain injury had a significantly lower survival rate 
than those who did not develop PTE 28. It has also 
been demonstrated that people developing PTE 
have more severe cognitive deficits and lower 
functional measures than brain injured people 
who do not develop PTE 29"30. Such work, 
however, brings out many questions: is it the 
seizures that directly effect brain recovery or is it 
the severity of brain injury that brings out PTE; 
does PTE have a detrimental effect on brain 
recovery or is it an effect of anticonvulsant 
therapy; can one isolate the effect of PTE on 
recovery from other variables, such as anticon- 
vulsant herapy? 
Animal experimental data suggest hat mild, 
infrequent seizures can facilitate behavioural 
recovery, whilst severe and/or recurrent seizures 
can have a detrimental impact T. As mentioned 
earlier, anticonvulsant drugs are commonly given 
prophylactically tohumans following brain injury, 
without any consideration of the effects on 
cognition and recovery of brain function, follow- 
ing brain injury. If 95% of brain injured people 
receive anticonvulsant drugs needlessly 3, subse- 
quent neuronal toxicity may potentially impair 
neurological recovery in 95% of brain injured 
people needlessly! Future research needs to 
address not only these questions, but also 
whether or not a partial prevention of seizures, 
that is, lower doses of anticonvulsant drugs which 
will consequently allow mild, infrequent seizures 
to occur, may favourably effect neurological 
recovery in humans. 
There is little evidence to support he prophyl- 
actic use of ffnticonvulsant drugs post traumatic 
brain injury. There is also little evidence on the 
effects of some of the more recent anticonvulsant 
drugs on recovery of brain function, post brain 
injury. It is clear, however, that most anticonvul- 
sant drugs enhance inhibition by augmenting 
GABA mechanisms, even those under clinical 
investigation for human epilepsy at present, e.g. 
Tiagabine-HCl (A GABA-reuptake inhibitor) 3~. 
Interestingly, it may be possible that mild, 
infrequent seizures could be beneficial to the 
recovering human brain, because 'post-traumatic 
seizures may be the result of adaptive mechan- 
isms initiated by the injured brain in an attempt to 
restore normal neuronal activity24. ' Thus, expos- 
ing such people to the toxicities of anticonvulsant 
drugs may have devasting consequences on the 
brain's recovery processes! 
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